Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127157702 | 12715770 | 2 | F | 20160810 | 20160901 | 20160906 | 20160908 | PER | US-PFIZER INC-2016413329 | PFIZER | 6.00 | YR | M | Y | 15.00000 | KG | 20160908 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127157702 | 12715770 | 1 | PS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 0.7 MG, UNK | U | 20280 | .7 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||
| 127157702 | 12715770 | 2 | SS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 0.8 MG, 6X/WEEK | U | 20280 | .8 | MG | POWDER FOR SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127157702 | 12715770 | 1 | Growth hormone deficiency |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127157702 | 12715770 | Abnormal behaviour | |
| 127157702 | 12715770 | Headache | |
| 127157702 | 12715770 | Personality change |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127157702 | 12715770 | 1 | 201512 | 0 | ||
| 127157702 | 12715770 | 2 | 201608 | 0 |